| scholarly article | Q13442814 |
| P2093 | author name string | Gonzalo Alvarez | |
| Javier O Morales | |||
| Johanna Catalan-Figueroa | |||
| Miguel O Jara | |||
| Hans F Fritz | |||
| Sujey Palma-Florez | |||
| P2860 | cites work | Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. | Q46793159 |
| Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation | Q47310313 | ||
| Special issue commentary: the changing face of inflammation in the brain. | Q48298066 | ||
| Chemotherapy of brain tumour using doxorubicin bound to surfactant-coated poly(butyl cyanoacrylate) nanoparticles: revisiting the role of surfactants | Q48346110 | ||
| Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo | Q48438523 | ||
| Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier | Q48520343 | ||
| Study of amphotericin B magnetic liposomes for brain targeting | Q48588190 | ||
| Induction of oxidative stress, lysosome activation and autophagy by nanoparticles in human brain-derived endothelial cells | Q48821785 | ||
| Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. | Q50757649 | ||
| Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. | Q51829536 | ||
| Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary titanium dioxide particles. | Q51842292 | ||
| Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. | Q53369656 | ||
| Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation | Q56484121 | ||
| Autophagy and neurodegeneration | Q57082951 | ||
| Drug transport across the blood-brain barrier | Q57677287 | ||
| Amino-Functionalized Polystyrene Nanoparticles Activate the NLRP3 Inflammasome in Human Macrophages | Q57947107 | ||
| Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage | Q22003729 | ||
| The blood-brain barrier: bottleneck in brain drug development | Q22336985 | ||
| Mechanisms of nanoparticle-induced oxidative stress and toxicity | Q23909817 | ||
| Understanding biophysicochemical interactions at the nano-bio interface | Q23909863 | ||
| Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity | Q23919994 | ||
| The ubiquitin proteasome system in neuropathology | Q24644208 | ||
| An overview of clinical and commercial impact of drug delivery systems | Q27007143 | ||
| Apg16p is required for the function of the Apg12p-Apg5p conjugate in the yeast autophagy pathway | Q27936903 | ||
| Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice | Q28131756 | ||
| Loss of autophagy in the central nervous system causes neurodegeneration in mice | Q28131804 | ||
| Emerging roles of caspase-3 in apoptosis | Q28141417 | ||
| Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease | Q28261987 | ||
| Identification of potential biomarkers of gold nanoparticle toxicity in rat brains | Q28387676 | ||
| Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity | Q28388552 | ||
| Molecular mechanism of titanium dioxide nanoparticles-induced oxidative injury in the brain of mice | Q43896126 | ||
| Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats | Q43951689 | ||
| Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts | Q44774544 | ||
| The challenge to relate the physicochemical properties of colloidal nanoparticles to their cytotoxicity | Q44914616 | ||
| Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size | Q46414402 | ||
| Toxicity and tissue distribution of magnetic nanoparticles in mice. | Q46764075 | ||
| In vivo nanoneurotoxicity screening using oxidative stress and neuroinflammation paradigms | Q28389093 | ||
| Autophagy: process and function | Q29547296 | ||
| Regulation mechanisms and signaling pathways of autophagy | Q29547416 | ||
| Microglia-mediated neurotoxicity: uncovering the molecular mechanisms | Q29547835 | ||
| Nanomaterials and nanoparticles: sources and toxicity | Q29615515 | ||
| Structure and function of the blood-brain barrier | Q29615699 | ||
| The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis | Q29617049 | ||
| Oxidative stress and neurodegeneration: where are we now? | Q29617324 | ||
| Carbon black and titanium dioxide nanoparticles elicit distinct apoptotic pathways in bronchial epithelial cells | Q30396943 | ||
| Time-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticles | Q33377703 | ||
| Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis | Q33622573 | ||
| The variability of autophagy and cell death susceptibility: Unanswered questions | Q33631208 | ||
| Parkin-mediated ubiquitin signalling in aggresome formation and autophagy | Q33757729 | ||
| CNS delivery via adsorptive transcytosis | Q34013526 | ||
| The nuclear factor NF-kappaB pathway in inflammation | Q34114512 | ||
| Toxicologic effects of gold nanoparticles in vivo by different administration routes | Q34231174 | ||
| Alzheimer's disease: cell-specific pathology isolates the hippocampal formation | Q34261572 | ||
| Drug delivery to the central nervous system by polymeric nanoparticles: what do we know? | Q34367038 | ||
| Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment | Q34400646 | ||
| Heat shock proteins: modifying factors in physiological stress responses and acquired thermotolerance | Q34605740 | ||
| COX-2 inhibitors and cardiovascular risk | Q34716335 | ||
| Principles and current strategies for targeting autophagy for cancer treatment | Q34787732 | ||
| Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein | Q35063363 | ||
| Brain Localization and Neurotoxicity Evaluation of Polysorbate 80-Modified Chitosan Nanoparticles in Rats | Q35739007 | ||
| ROS stress in cancer cells and therapeutic implications | Q35781703 | ||
| The cell biology of lysosomal storage disorders | Q35825859 | ||
| Noninvasive detection of neural progenitor cells in living brains by MRI | Q35863775 | ||
| Modulation of neurodegeneration by molecular chaperones | Q35990274 | ||
| Lysosomes and autophagy in cell death control | Q36292872 | ||
| Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response | Q36355862 | ||
| Biomedical applications and potential health risks of nanomaterials: molecular mechanisms | Q36615255 | ||
| Targeted cancer therapy: conferring specificity to cytotoxic drugs | Q36912991 | ||
| Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials? | Q36927008 | ||
| Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway. | Q37003169 | ||
| A delicate balance: Iron metabolism and diseases of the brain. | Q37023585 | ||
| Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease | Q37178375 | ||
| The activation sequence of cellular protein handling systems after proteasomal inhibition in dopaminergic cells | Q37200707 | ||
| Drug interactions at the blood-brain barrier: fact or fantasy? | Q37362486 | ||
| Monocyte chemoattractant protein-1 (MCP-1): an overview | Q37481208 | ||
| Mammalian macroautophagy at a glance | Q37491912 | ||
| Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases | Q37576225 | ||
| Musculoskeletal manifestations of lysosomal storage disorders. | Q37613315 | ||
| Alkylation damage by lipid electrophiles targets functional protein systems | Q37623645 | ||
| The role of autophagy in tumour development and cancer therapy. | Q37642093 | ||
| Pathophysiology of neuropathic lysosomal storage disorders | Q37739318 | ||
| Potential neurotoxicity of nanoparticles | Q37740266 | ||
| Selective autophagy regulates various cellular functions | Q37776534 | ||
| Selective degradation of p62 by autophagy | Q37785017 | ||
| Regulation of mammalian autophagy in physiology and pathophysiology. | Q37801517 | ||
| Changing face of microglia | Q37807203 | ||
| Autophagic pathways in Parkinson disease and related disorders | Q37854912 | ||
| A clinical perspective: anti tau's treatment in Alzheimer's disease. | Q37878505 | ||
| Transport of drugs across the blood-brain barrier by nanoparticles. | Q37923068 | ||
| Nanobiotechnology-based strategies for crossing the blood-brain barrier | Q38038895 | ||
| Unravelling mitochondrial pathways to Parkinson's disease | Q38151760 | ||
| Recent advances in delivery through the blood-brain barrier | Q38200122 | ||
| A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. | Q38239644 | ||
| The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers | Q38987462 | ||
| Titanium dioxide nanoparticles induce strong oxidative stress and mitochondrial damage in glial cells | Q38995292 | ||
| Drug delivery by polymeric nanoparticles induces autophagy in macrophages | Q39436846 | ||
| Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles | Q39440577 | ||
| Cancer-cell-specific cytotoxicity of non-oxidized iron elements in iron core-gold shell NPs. | Q39601819 | ||
| Autophagy and oxidative stress associated with gold nanoparticles | Q39704265 | ||
| Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters | Q39799499 | ||
| Intracellular protein degradation in mammalian and bacterial cells | Q39944708 | ||
| Multiple mechanisms underlying the anticancer action of nanocrystalline fullerene | Q40121459 | ||
| Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells. | Q40368887 | ||
| A new definition of Alzheimer's disease: a hippocampal dementia | Q41339111 | ||
| Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 | ||
| Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus | Q42513005 | ||
| Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro | Q42716163 | ||
| TiO₂ nanoparticles induce dysfunction and activation of human endothelial cells. | Q42721076 | ||
| The role of mitochondrial function in gold nanoparticle mediated radiosensitisation. | Q42878512 | ||
| The FAP motif within human ATG7, an autophagy-related E1-like enzyme, is essential for the E2-substrate reaction of LC3 lipidation | Q43405496 | ||
| Mechanism of polymeric nanoparticle-based drug transport across the blood-brain barrier (BBB). | Q43679314 | ||
| P433 | issue | 2 | |
| P921 | main subject | nanomedicine | Q261659 |
| neurodegeneration | Q1755122 | ||
| brain cancer | Q9303627 | ||
| P304 | page(s) | 171-187 | |
| P577 | publication date | 2015-12-11 | |
| P1433 | published in | Nanomedicine | Q15817508 |
| P1476 | title | Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer | |
| P478 | volume | 11 |
| Q58555868 | Biomimetic quantum dot-labeled B16F10 murine melanoma cells as a tool to monitor early steps of lung metastasis by in vivo imaging |
| Q47859436 | Central neurotoxicity induced by the instillation of ZnO and TiO2 nanoparticles through the taste nerve pathway. |
| Q64102679 | Neuronanomedicine: An Up-to-Date Overview |
| Q46290936 | Redox-active nanomaterials for nanomedicine applications |
Search more.